MedTrace Logo

μ-opioid Receptor Polymorphism and Opioid Analgesia

NCT02099877 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2018-02-22

No results posted yet for this study

Summary

In this prospective observational double-blind study, the investigators aim to assess the effect of the single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1, p.118A/G) on the duration of epidural fentanyl labor analgesia.

Conditions

  • Pharmacogenetic and Duration of Labor Fentanyl Analgesia

Interventions

DRUG

Fentanyl

Epidural analgesia will be initiated with 100µg of epidural fentanyl

Sponsors & Collaborators

  • American University of Beirut Medical Center

    lead OTHER

Principal Investigators

  • Sahar Siddik Sayyid, MD · American Univesity of Beirut

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2017-06-30
Completion
2017-06-30

Countries

  • Lebanon

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02099877 on ClinicalTrials.gov